APO Research, Inc.

APO RESEARCH · REPORT

Allergy Vaccine

Selected research

Market Analysis & Forecast

Global Allergy Vaccine Market Analysis and Forecast 2026-2032

Market perspective

The global Allergy Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Allergy Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Allergy Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Allergy Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Allergy Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Allergy Vaccine include ALK-Abello, Allergy Therapeutics, HAL, Holister Stier, Leti, Stallergenes Greer, WOLW Pharma and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Allergy Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Allergy Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Allergy Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Allergy Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Allergy Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Allergy Vaccine sales, projected growth trends, production technology, application and end-user industry.

Allergy Vaccine Segment by Company

ALK-Abello

Allergy Therapeutics

HAL

Holister Stier

Leti

Stallergenes Greer

WOLW Pharma

Merck

Allergy Vaccine Segment by Type

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Allergy Vaccine Segment by Application

Allergic Rhinitis

Allergic Asthma

Other

Allergy Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Allergy Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Allergy Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Allergy Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Allergy Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Subcutaneous Immunotherapy Major Manufacturers Table 3. Sublingual Immunotherapy Major Manufacturers Table 4. Global Allergy Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Allergic Rhinitis Major Manufacturers Table 6. Allergic Asthma Major Manufacturers Table 7. Other Major Manufacturers Table 8. Allergy Vaccine Industry Trends Table 9. Allergy Vaccine Industry Drivers Table 10. Allergy Vaccine Industry Opportunities and Challenges Table 11. Allergy Vaccine Industry Restraints Table 12. Global Allergy Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Allergy Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Allergy Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Allergy Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global Allergy Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global Allergy Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Allergy Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global Allergy Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global Allergy Vaccine Sales Market Share by Region (2021-2026) Table 21. Global Allergy Vaccine Sales Market Share by Region (2027-2032) Table 22. Global Allergy Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Allergy Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Allergy Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Allergy Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global Allergy Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Allergy Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Allergy Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Allergy Vaccine Manufacturers, Product Type & Application Table 30. Global Allergy Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Allergy Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Allergy Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Allergy Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Allergy Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Allergy Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global Allergy Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global Allergy Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global Allergy Vaccine Sales Market Share by Type (2021-2026) Table 42. Global Allergy Vaccine Sales Market Share by Type (2027-2032) Table 43. Global Allergy Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global Allergy Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global Allergy Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Allergy Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Allergy Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Allergy Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global Allergy Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global Allergy Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global Allergy Vaccine Sales Market Share by Application (2021-2026) Table 54. Global Allergy Vaccine Sales Market Share by Application (2027-2032) Table 55. Global Allergy Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Allergy Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. ALK-Abello Company Information Table 58. ALK-Abello Business Overview Table 59. ALK-Abello Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. ALK-Abello Allergy Vaccine Product Portfolio Table 61. ALK-Abello Recent Development Table 62. Allergy Therapeutics Company Information Table 63. Allergy Therapeutics Business Overview Table 64. Allergy Therapeutics Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Allergy Therapeutics Allergy Vaccine Product Portfolio Table 66. Allergy Therapeutics Recent Development Table 67. HAL Company Information Table 68. HAL Business Overview Table 69. HAL Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. HAL Allergy Vaccine Product Portfolio Table 71. HAL Recent Development Table 72. Holister Stier Company Information Table 73. Holister Stier Business Overview Table 74. Holister Stier Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Holister Stier Allergy Vaccine Product Portfolio Table 76. Holister Stier Recent Development Table 77. Leti Company Information Table 78. Leti Business Overview Table 79. Leti Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Leti Allergy Vaccine Product Portfolio Table 81. Leti Recent Development Table 82. Stallergenes Greer Company Information Table 83. Stallergenes Greer Business Overview Table 84. Stallergenes Greer Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Stallergenes Greer Allergy Vaccine Product Portfolio Table 86. Stallergenes Greer Recent Development Table 87. WOLW Pharma Company Information Table 88. WOLW Pharma Business Overview Table 89. WOLW Pharma Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. WOLW Pharma Allergy Vaccine Product Portfolio Table 91. WOLW Pharma Recent Development Table 92. Merck Company Information Table 93. Merck Business Overview Table 94. Merck Allergy Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Merck Allergy Vaccine Product Portfolio Table 96. Merck Recent Development Table 97. North America Allergy Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Allergy Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 100. North America Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 101. North America Allergy Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 102. North America Allergy Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 103. North America Allergy Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Allergy Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 106. North America Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 107. North America Allergy Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 108. North America Allergy Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 109. North America Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Allergy Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Allergy Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 113. North America Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 114. North America Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 115. North America Allergy Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 116. North America Allergy Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 117. United States Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 118. Canada Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 119. Europe Allergy Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Allergy Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 122. Europe Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 123. Europe Allergy Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 124. Europe Allergy Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 125. Europe Allergy Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 126. Europe Allergy Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 127. Europe Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 128. Europe Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 129. Europe Allergy Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 130. Europe Allergy Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 131. Europe Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Allergy Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 133. Europe Allergy Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 134. Europe Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 135. Europe Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 136. Europe Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 137. Europe Allergy Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 138. Europe Allergy Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 139. Germany Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 140. France Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 141. U.K. Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Italy Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 144. China Allergy Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 145. China Allergy Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 146. China Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 147. China Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 148. China Allergy Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 149. China Allergy Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 150. China Allergy Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 151. China Allergy Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 152. China Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 153. China Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 154. China Allergy Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 155. China Allergy Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 156. Asia Allergy Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Allergy Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 159. Asia Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 160. Asia Allergy Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Asia Allergy Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Asia Allergy Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Allergy Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 165. Asia Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 166. Asia Allergy Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Asia Allergy Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Asia Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Allergy Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Allergy Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. Asia Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 173. Asia Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 174. Asia Allergy Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Asia Allergy Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Japan Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 177. South Korea Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 178. India Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Australia Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 180. China Taiwan Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Allergy Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Allergy Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Allergy Vaccine Sales by Type (2021-2026) & (K Units) Table 185. SAMEA Allergy Vaccine Sales by Type (2027-2032) & (K Units) Table 186. SAMEA Allergy Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 187. SAMEA Allergy Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 188. SAMEA Allergy Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Allergy Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Allergy Vaccine Sales by Application (2021-2026) & (K Units) Table 191. SAMEA Allergy Vaccine Sales by Application (2027-2032) & (K Units) Table 192. SAMEA Allergy Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 193. SAMEA Allergy Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 194. SAMEA Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Allergy Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Allergy Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. SAMEA Allergy Vaccine Sales by Country (2021-2026) & (K Units) Table 199. SAMEA Allergy Vaccine Sales by Country (2027-2032) & (K Units) Table 200. SAMEA Allergy Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 201. SAMEA Allergy Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Brazil Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 203. Argentina Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 204. Chile Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Colombia Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Peru Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Israel Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 209. UAE Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Turkey Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 211. Iran Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Egypt Allergy Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Allergy Vaccine Distributors List Table 216. Allergy Vaccine Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Allergy Vaccine Image Figure 2. Global Allergy Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allergy Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Subcutaneous Immunotherapy Image Figure 5. Sublingual Immunotherapy Image Figure 6. Global Allergy Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Allergy Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Allergic Rhinitis Image Figure 9. Allergic Asthma Image Figure 10. Other Image Figure 11. Global Allergy Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Allergy Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global Allergy Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Allergy Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Allergy Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global Allergy Vaccine Sales (2021-2032) & (K Units) Figure 17. Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Allergy Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Allergy Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe Allergy Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China Allergy Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Allergy Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Allergy Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global Allergy Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Allergy Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Allergy Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Allergy Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Allergy Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global Allergy Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Allergy Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Allergy Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global Allergy Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Allergy Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Allergy Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global Allergy Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Allergy Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Allergy Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America Allergy Vaccine Revenue Share by Type (2021-2032) Figure 40. North America Allergy Vaccine Sales Share by Type (2021-2032) Figure 41. North America Allergy Vaccine Revenue Share by Application (2021-2032) Figure 42. North America Allergy Vaccine Sales Share by Application (2021-2032) Figure 43. North America Allergy Vaccine Revenue Share by Country (2021-2032) Figure 44. North America Allergy Vaccine Sales Share by Country (2021-2032) Figure 45. Europe Allergy Vaccine Revenue Share by Type (2021-2032) Figure 46. Europe Allergy Vaccine Sales Share by Type (2021-2032) Figure 47. Europe Allergy Vaccine Revenue Share by Application (2021-2032) Figure 48. Europe Allergy Vaccine Sales Share by Application (2021-2032) Figure 49. Europe Allergy Vaccine Revenue Share by Country (2021-2032) Figure 50. Europe Allergy Vaccine Sales Share by Country (2021-2032) Figure 51. China Allergy Vaccine Revenue Share by Type (2021-2032) Figure 52. China Allergy Vaccine Sales Share by Type (2021-2032) Figure 53. China Allergy Vaccine Revenue Share by Application (2021-2032) Figure 54. China Allergy Vaccine Sales Share by Application (2021-2032) Figure 55. Asia Allergy Vaccine Revenue Share by Type (2021-2032) Figure 56. Asia Allergy Vaccine Sales Share by Type (2021-2032) Figure 57. Asia Allergy Vaccine Revenue Share by Application (2021-2032) Figure 58. Asia Allergy Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Allergy Vaccine Revenue Share by Country (2021-2032) Figure 60. Asia Allergy Vaccine Sales Share by Country (2021-2032) Figure 61. SAMEA Allergy Vaccine Revenue Share by Type (2021-2032) Figure 62. SAMEA Allergy Vaccine Sales Share by Type (2021-2032) Figure 63. SAMEA Allergy Vaccine Revenue Share by Application (2021-2032) Figure 64. SAMEA Allergy Vaccine Sales Share by Application (2021-2032) Figure 65. SAMEA Allergy Vaccine Revenue Share by Country (2021-2032) Figure 66. SAMEA Allergy Vaccine Sales Share by Country (2021-2032) Figure 67. Allergy Vaccine Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Allergy Vaccine Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Applications
  • Allergic Rhinitis
  • Allergic Asthma
  • Other
Companies covered
  • ALK-Abello
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti
  • Stallergenes Greer
  • WOLW Pharma
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Allergy Vaccine Market by Type
  3. 1.2.1 Global Allergy Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Subcutaneous Immunotherapy
  5. 1.2.3 Sublingual Immunotherapy
  6. 1.3 Allergy Vaccine Market by Application
  7. 1.3.1 Global Allergy Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Allergic Rhinitis
  9. 1.3.3 Allergic Asthma
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Allergy Vaccine Market Dynamics
  1. 2.1 Allergy Vaccine Industry Trends
  2. 2.2 Allergy Vaccine Industry Drivers
  3. 2.3 Allergy Vaccine Industry Opportunities and Challenges
  4. 2.4 Allergy Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Allergy Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Allergy Vaccine Revenue by Region
  3. 3.2.1 Global Allergy Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Allergy Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Allergy Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Allergy Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Allergy Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Allergy Vaccine Sales by Region
  9. 3.4.1 Global Allergy Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Allergy Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Allergy Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Allergy Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Allergy Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Allergy Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Allergy Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Allergy Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Allergy Vaccine Sales by Manufacturers
  6. 4.2.1 Global Allergy Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Allergy Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Allergy Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Allergy Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Allergy Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Allergy Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Allergy Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Allergy Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Allergy Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Allergy Vaccine Tier 1, Tier 2, and Tier 3
5 Allergy Vaccine Market by Type
  1. 5.1 Global Allergy Vaccine Revenue by Type
  2. 5.1.1 Global Allergy Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Allergy Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Allergy Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Allergy Vaccine Sales by Type
  6. 5.2.1 Global Allergy Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Allergy Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Allergy Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Allergy Vaccine Price by Type
6 Allergy Vaccine Market by Application
  1. 6.1 Global Allergy Vaccine Revenue by Application
  2. 6.1.1 Global Allergy Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Allergy Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Allergy Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Allergy Vaccine Sales by Application
  6. 6.2.1 Global Allergy Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Allergy Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Allergy Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Allergy Vaccine Price by Application
7 Company Profiles
  1. 7.1 ALK-Abello
  2. 7.1.1 ALK-Abello Company Information
  3. 7.1.2 ALK-Abello Business Overview
  4. 7.1.3 ALK-Abello Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ALK-Abello Allergy Vaccine Product Portfolio
  6. 7.1.5 ALK-Abello Recent Developments
  7. 7.2 Allergy Therapeutics
  8. 7.2.1 Allergy Therapeutics Company Information
  9. 7.2.2 Allergy Therapeutics Business Overview
  10. 7.2.3 Allergy Therapeutics Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Allergy Therapeutics Allergy Vaccine Product Portfolio
  12. 7.2.5 Allergy Therapeutics Recent Developments
  13. 7.3 HAL
  14. 7.3.1 HAL Company Information
  15. 7.3.2 HAL Business Overview
  16. 7.3.3 HAL Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 HAL Allergy Vaccine Product Portfolio
  18. 7.3.5 HAL Recent Developments
  19. 7.4 Holister Stier
  20. 7.4.1 Holister Stier Company Information
  21. 7.4.2 Holister Stier Business Overview
  22. 7.4.3 Holister Stier Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Holister Stier Allergy Vaccine Product Portfolio
  24. 7.4.5 Holister Stier Recent Developments
  25. 7.5 Leti
  26. 7.5.1 Leti Company Information
  27. 7.5.2 Leti Business Overview
  28. 7.5.3 Leti Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Leti Allergy Vaccine Product Portfolio
  30. 7.5.5 Leti Recent Developments
  31. 7.6 Stallergenes Greer
  32. 7.6.1 Stallergenes Greer Company Information
  33. 7.6.2 Stallergenes Greer Business Overview
  34. 7.6.3 Stallergenes Greer Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Stallergenes Greer Allergy Vaccine Product Portfolio
  36. 7.6.5 Stallergenes Greer Recent Developments
  37. 7.7 WOLW Pharma
  38. 7.7.1 WOLW Pharma Company Information
  39. 7.7.2 WOLW Pharma Business Overview
  40. 7.7.3 WOLW Pharma Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 WOLW Pharma Allergy Vaccine Product Portfolio
  42. 7.7.5 WOLW Pharma Recent Developments
  43. 7.8 Merck
  44. 7.8.1 Merck Company Information
  45. 7.8.2 Merck Business Overview
  46. 7.8.3 Merck Allergy Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Merck Allergy Vaccine Product Portfolio
  48. 7.8.5 Merck Recent Developments
8 North America
  1. 8.1 North America Allergy Vaccine Market Size by Type
  2. 8.1.1 North America Allergy Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Allergy Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Allergy Vaccine Price by Type (2021-2032)
  5. 8.2 North America Allergy Vaccine Market Size by Application
  6. 8.2.1 North America Allergy Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Allergy Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Allergy Vaccine Price by Application (2021-2032)
  9. 8.3 North America Allergy Vaccine Market Size by Country
  10. 8.3.1 North America Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Allergy Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Allergy Vaccine Market Size by Type
  2. 9.1.1 Europe Allergy Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Allergy Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Allergy Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Allergy Vaccine Market Size by Application
  6. 9.2.1 Europe Allergy Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Allergy Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Allergy Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Allergy Vaccine Market Size by Country
  10. 9.3.1 Europe Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Allergy Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Allergy Vaccine Market Size by Type
  2. 10.1.1 China Allergy Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Allergy Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Allergy Vaccine Price by Type (2021-2032)
  5. 10.2 China Allergy Vaccine Market Size by Application
  6. 10.2.1 China Allergy Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Allergy Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Allergy Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Allergy Vaccine Market Size by Type
  2. 11.1.1 Asia Allergy Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Allergy Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Allergy Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Allergy Vaccine Market Size by Application
  6. 11.2.1 Asia Allergy Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Allergy Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Allergy Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Allergy Vaccine Market Size by Country
  10. 11.3.1 Asia Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Allergy Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Allergy Vaccine Market Size by Type
  2. 12.1.1 SAMEA Allergy Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Allergy Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Allergy Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Allergy Vaccine Market Size by Application
  6. 12.2.1 SAMEA Allergy Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Allergy Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Allergy Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Allergy Vaccine Market Size by Country
  10. 12.3.1 SAMEA Allergy Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Allergy Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Allergy Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Allergy Vaccine Value Chain Analysis
  2. 13.1.1 Allergy Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Allergy Vaccine Production Mode & Process
  6. 13.2 Allergy Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Allergy Vaccine Distributors
  9. 13.2.3 Allergy Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.